President Trump's White House announcement on autism, featuring HHS Secretary Robert F. Kennedy Jr., advised against Tylenol use during pregnancy and infancy, citing a study by researcher Ann Bauer. Bauer, while her research suggested cautious Tylenol use, expressed alarm at Trump's sweeping claims, which lacked evidence and omitted crucial context. The announcement bypassed CDC consultation, raising concerns about scientific integrity. Experts criticized the administration's approach, highlighting the complex nature of autism and the potential for misinformation to harm public health. Concerns were raised about the administration's actions undermining scientific research and credibility.
Reviewed by JQJO team
#trump #rfkjr #autism #vaccines #misinformation
Comments